| P2093 | author name string | Partha S Biswas | |
| | Marc C Levesque | |
| | Rohit Aggarwal | |
| | Kritika Ramani | |
| | Kelly Maers | |
| P2860 | cites work | Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 |
| | Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients. | Q45928071 |
| | IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells | Q46043684 |
| | Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation | Q46772835 |
| | IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice | Q47901598 |
| | Systemic lupus erythematosus. | Q53202066 |
| | IFN-beta modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression. | Q54431573 |
| | Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. | Q54664586 |
| | A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. | Q55045567 |
| | Rationale for interleukin-6 blockade in systemic lupus erythematosus | Q24564990 |
| | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 |
| | Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells | Q33500436 |
| | T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus? | Q33765598 |
| | Type I interferon in the pathogenesis of lupus | Q33852174 |
| | Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice | Q34080154 |
| | Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice | Q34090173 |
| | Interleukin 6 promotes murine lupus in NZB/NZW F1 mice | Q34228814 |
| | From T to B and back again: positive feedback in systemic autoimmune disease | Q34572168 |
| | The dysregulation of cytokine networks in systemic lupus erythematosus | Q35294513 |
| | Recent advances in the IL-17 cytokine family | Q35301277 |
| | Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. | Q35592657 |
| | The emerging role of interferon in human systemic lupus erythematosus | Q35931596 |
| | Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells | Q36373858 |
| | The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice | Q36512209 |
| | Type I interferon in systemic lupus erythematosus and other autoimmune diseases | Q36595839 |
| | Systemic lupus erythematosus: all roads lead to type I interferons | Q36608558 |
| | Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis | Q36676453 |
| | Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. | Q37202267 |
| | Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway | Q37292757 |
| | The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 |
| | Interleukin-17 and systemic lupus erythematosus: current concepts | Q37552021 |
| | Activating systemic autoimmunity: B's, T's, and tolls. | Q37607510 |
| | Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosis | Q37729213 |
| | Interleukin-17-producing T cells in lupus | Q37769076 |
| | IL-17-producing T cells in lupus nephritis | Q37838092 |
| | The immunobiology of IL-27. | Q38011355 |
| | IL-17: a new actor in IFN-driven systemic autoimmune diseases | Q38040748 |
| | Th17 cell development: from the cradle to the grave | Q38081169 |
| | Advances in understanding the role of type I interferons in systemic lupus erythematosus | Q38227972 |
| | Measuring interferon alpha and other cytokines in SLE. | Q39027121 |
| P433 | issue | 6 | |
| P304 | page(s) | 646-653 | |
| P577 | publication date | 2015-05-11 | |
| P1433 | published in | International Journal of Rheumatic Diseases | Q15764244 |
| P1476 | title | Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients. | |
| P478 | volume | 18 | |